Carter Percy H.

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
6
Insider Sells Sum
$1.16M

Insider Activity of Carter Percy H.

According to the SEC Form 4 filings, Carter Percy H., being in a position of

  1. CHIEF SCIENTIFIC OFFICER at Blueprint Medicines Corporation,
    оver the last 12 months, has bought 0 shares, and sold 8722 shares for $887,101,
    over all time since 2022-06-06, has bought 0 shares, and sold 13698 shares for $1.16M.

The largest sale of all time was on 2024-06-05 and amounted to 4000 shares of Blueprint Medicines Corporation for $420,520.

Biography of Carter Percy H.

No biography is available at this moment.

2024-06-05SaleBlueprint Medicines Corporation
BPMC
CHIEF SCIENTIFIC OFFICER
4,000
0.0063%
$105.13$420,520-11.26%
2024-06-03SaleBlueprint Medicines Corporation
BPMC
CHIEF SCIENTIFIC OFFICER
2,436
0.0039%
$106.43$259,263-10.4%
2024-03-07SaleBlueprint Medicines Corporation
BPMC
CHIEF SCIENTIFIC OFFICER
2,286
0.0037%
$90.69$207,317+1.64%
2023-06-05SaleBlueprint Medicines Corporation
BPMC
CHIEF SCIENTIFIC OFFICER
2,307
0.0036%
$52.06$120,102+29.45%
2023-03-06SaleBlueprint Medicines Corporation
BPMC
761
0.0013%
$45.69$34,769+32.68%
2022-06-06SaleBlueprint Medicines Corporation
BPMC
CHIEF SCIENTIFIC OFFICER
1,908
0.0033%
$59.76$114,022-15.34%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.